HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 544280Generated: October 25, 2026
Phenylhydrazine → 3-Amino-1-phenylpyrazole
https://huagongshe.com/reaction/544280
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Phenylhydrazine | HCID 7516 | — |
| Reactant | Acrylonitrile | HCID 7855 | — |
| Reactant | Propanenitrile, 3-ethoxy- | HCID 16501 | — |
| Reactant | Methacrylonitrile | HCID 31368 | — |
| Reactant | Hydrazine, (4-chlorophenyl)-, hydrochloride (1:1) | HCID 71600 | — |
| Reactant | 3-Phenylprop-2-enenitrile | HCID 74667 | — |
| Reactant | m-Chlorophenylhydrazine hydrochloride | HCID 75331 | — |
| Reactant | 2-Butylacrylonitrile | HCID 524765 | — |
| Reactant | Crotononitrile | HCID 637921 | — |
| Reactant | 3-Fluorophenylhydrazine hydrochloride | HCID 2723914 | — |
| Reactant | Sodium ethoxide | HCID 2723922 | — |
| Reactant | (3,4-Dichlorophenyl)hydrazine monohydrochloride | HCID 3084323 | — |
| Reactant | Choline hydrate | HCID 20195019 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | 3-Amino-1-phenylpyrazole | HCID 98736 | — |
| Product | 2,3-dihydro-1H-pyrazole | HCID 4156003 | — |
Reaction Steps
Preparation of the novel 3-substituted amino-1-phenyl-2-pyrazoline and 3-substituted amino-1-substituted phenyl-2-pyrazoline compounds V of the instant invention, which exhibit the pharmaceutical activity as herein described, is accomplished by the adaptation of the procedure of Duffin, G. F. and Kendall, J. D., J. Chem. Soc., 1954, 408; with modifications in accordance with the following reaction scheme: ##STR6## wherein R1, R2 and R3 are as previously defined. In accordance with the above reaction scheme, phenylhydrazine or a halogen-mono or disubstituted phenylhydrazine hydrochloride II such as p-chlorophenylhydrazine hydrochloride, m-chlorophenylhydrazine hydrochloride, m-fluorophenylhydrazine hydrochloride or 3,4-dichlorophenylhydrazine hydrochloride is reacted with an α, β-unsaturated nitrile I, such as acrylonitrile, methacrylonitrile, crotononitrile, cinnamonitrile, butyl acrylonitrile or compounds such as β-ethoxypropionitrile (which can undergo base catalyzed elimination to yield I) in a base catalyzed condensation procedure, with a base such as sodium ethoxide or choline hydrate in absolute ethanol. The reaction mixture is refluxed for a period of from 2-18 hours then the solvent is removed in vacuo. The addition of water gives a filterable solid which is collected, dissolved in dichloromethane and passed through a short column of a hydrous magnesium silicate. The column effluent is then refluxed on a steam bath with the gradual addition of hexane until crystallization is noted. Recrystallization from the same solvent pair (with or without additional treatment with a hydrous magnesium silicate) or from acetone-hexane provides the 3-amino-1-phenyl-2-pyrazoline and 3-amino-1-mono and disubstituted phenyl-2-pyrazoline compounds III. If the pyrazoline III is not soluble in dichloromethane, recrystallization may be accomplished from acetone-hexane, 95% ethanol or benzene with the omission of the hydrous magnesium silicate treatment phase.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04448973 |
|---|
| Source dataset | uspto-grants-1984_05 |
|---|
| ORD ID | ord-9809a54f1be64fe2aab35cad871d3b28 |
|---|
| Source note | uspto-grants-1984_05 |
|---|